Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

BMC Infectious Diseases

Table 2 High grade cervical smear cytology report by age and ethnicity among study participants and among women on the National Cervical Screening Programme-Register (NCSP-R) in New Zealand* [15]

	Study population participants		NCSP-R∫
	n	%	N (Jan-Jun 2009)	%
Age groups
20-24	148	24.9	514	22.9
25-29	136	22.9	479	21.4
30-34	92	15.5	348	15.5
35-39	79	13.3	279	12.4
40-44	52	8.8	179	8.0
45-49	34	5.7	165	7.4
50-54	25	4.2	102	4.6
55-59	17	2.9	69	3.1
60-64	7	1.2	73	3.3
65-69	4	0.7	34	1.5
Ethnicity groups
European/Other	466	78.5	1678	74.9
Maori	98	16.5	367	16.4
Asian	16	2.7	127	5.7
Pacific	14	2.4	70	3.1
Total	594	100	2242	100

* The New Zealand NSCP-R contains cervical cytology results for all women in New Zealand, with the exception of those who choose to opt-off . For the study, and on the NCSP-R, a high grade cytology report includes women with a reported cytology result of either high grade squamous intra-epithelial lesion (HSIL), atypical squamous cells, cannot rule out a high grade lesion (ASC-H), atypical glandular cells(AGC), adenocarcinoma in situ (AIS) or cytology suggestive of invasive cancer (SC, AC1-AC5).
∫ Screened women with high grade cytology as reported in New Zealand for the period 1st January-30th June 2009[15].

ISSN: 1471-2334